Inventor · disambiguated record
Antonin Holy
Also filed as: HOLY ANTONIN
20 granted patents·2 pending applications·1,175 citations·filing 1978–2012
96Inventor score
Files withACAD OF SCIENCE CZECH REPUBLIC11CESKOSLOVENSKA AKADEMIE VED5STICHTING REGA V Z W2BIOCHEMISTRY OF THE ACADEMY OF1HOLY ANTONIN1
Top patents by PatentIndex Score
22 records- 0197US5142051AN-phosphonylmethoxyalkyl derivatives of pyrimidine and purine bases and a therapeutical composition therefrom with antiviral activityCESKOSLOVENSKA AKADEMIE VED·Filed 1987·Granted Aug 25, 1992·135 cites·3 claims
- 0296US6653296B1Antiretroviral enantiomeric nucleotide analogsACAD OF SCIENCE CZECH REPUBLIC·Filed 1993·Granted Nov 25, 2003·118 cites·40 claims
- 0396US5977061AN6 - substituted nucleotide analagues and their useACAD OF SCIENCE CZECH REPUBLIC·Filed 1995·Granted Nov 2, 1999·236 cites·33 claims
- 0496US4808716A9-(phosponylmethoxyalkyl) adenines, the method of preparation and utilization thereofCESKOSLOVENSKA AKADEMIE VED·Filed 1986·Granted Feb 28, 1989·144 cites·2 claims
- 0595US6057305AAntiretroviral enantiomeric nucleotide analogsACAD OF SCIENCE CZECH REPUBLIC·Filed 1992·Granted May 2, 2000·157 cites·2 claims
- 0695US4724233ATherapeutical application of phosphonylmethoxyalkyl adeninesSTICHTING REGA V Z W·Filed 1986·Granted Feb 9, 1988·114 cites·12 claims
- 0794US4659825AIsomeric O-phosphonylmethyl derivatives of enantiomeric and racemic 9-(2,3-dihydroxypropyl)adenineCESKOSLOVENSKA AKADEMIE VED·Filed 1984·Granted Apr 21, 1987·72 cites·1 claims
- 0890US4230708ATherapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agentsSTICHTING REGA V Z W·Filed 1978·Granted Oct 28, 1980·18 cites·2 claims
- 0984US5641763AN-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a therapeutical composition therefrom with antiviral activityACAD OF SCIENCE CZECH REPUBLIC·Filed 1994·Granted Jun 24, 1997·39 cites·40 claims
- 1084US5130427A(2R)-2-[di(2-propyl)phosphonylmethoxy]-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane, its preparation and useCESKOSLOVENSKA AKADEMIE VED·Filed 1991·Granted Jul 14, 1992·26 cites·5 claims
- 1183US4605658AAntivirally active adenine derivativesCESKOSLOVENSKA AKADEMIE VED·Filed 1984·Granted Aug 12, 1986·13 cites·20 claims
- 1278US5869467A9-(2-phosphonylmethoxyethyl) guanineACAD OF SCIENCE CZECH REPUBLIC·Filed 1995·Granted Feb 9, 1999·32 cites·2 claims
- 1375US5733896AN-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and useACAD OF SCIENCE CZECH REPUBLIC·Filed 1994·Granted Mar 31, 1998·33 cites·16 claims
- 1474US6818633B2Antiviral compounds and methods for synthesis and therapyACAD OF SCIENCE CZECH REPUBLIC·Filed 2002·Granted Nov 16, 2004·6 cites·39 claims
- 1573US7115592B2Phosphonate substituted pyrimidine compounds and methods for therapyBIOCHEMISTRY OF THE ACADEMY OF·Filed 2004·Granted Oct 3, 2006·10 cites·34 claims
- 1672US5352786ADi(2-propyl)esters of 1-fluoro-2-phosphonomethoxy-3-P-to-luenesulfonyloxypropanes, their producing and utilizationACAD OF SCIENCE CZECH REPUBLIC·Filed 1992·Granted Oct 4, 1994·16 cites·7 claims
- 1770US6479673B1Antiretroviral enantiomeric nucleotide analogsACAD OF SCIENCE CZECH REPUBLIC·Filed 2000·Granted Nov 12, 2002·5 cites·6 claims
- 1854US2005038058A1Novel compounds and methods for therapyACAD OF SCIENCE CZECH REPUBLIC·Filed 2004·Application pending·0 cites
- 1953US8883798B2Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereofJANSA PETR·Filed 2012·Granted Nov 11, 2014·1 cites·5 claims
- 2050US2006241081A1Novel compounds and methods for therapyREGA STICHTING·Filed 2006·Application pending·0 cites
- 2131USRE35558E(2R)-2-[di(2-propyl)phosphonyylmethoxy]-3-P-toluenesulfonyloxy-1-trimethylacetoxypropane, its preparation and useACAD OF SCIENCE CZECH REPUBLIC·Filed 1994·Granted Jul 8, 1997·0 cites·5 claims
- 2226US8153787B2Azacytosine derivatives useful as antiviral agentsHOLY ANTONIN·Filed 2006·Granted Apr 10, 2012·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →